SOLICITATION NOTICE
68 -- Purchase of Dengue Antigen Mix, Chik Antigen, and Zika Antigen
- Notice Date
- 2/17/2017
- Notice Type
- Presolicitation
- NAICS
- 325413
— In-Vitro Diagnostic Substance Manufacturing
- Contracting Office
- Department of Health and Human Services, Centers for Disease Control and Prevention, Procurement and Grants Office (Atlanta), 2920 Brandywine Road, Room 3000, Atlanta, Georgia, 30341-4146
- ZIP Code
- 30341-4146
- Solicitation Number
- 2017-Q-66378
- Archive Date
- 3/19/2017
- Point of Contact
- Liubov A. Kriel, Phone: 7704882856
- E-Mail Address
-
vyh1@cdc.gov
(vyh1@cdc.gov)
- Small Business Set-Aside
- N/A
- Description
- The Center for Disease Control and Prevention (CDC), the National Center for Emerging and Zoonotic Infectious Diseases (NCEZID), intends to award a sole source purchase order to Inbios International, Inc., 562 1st Ave S, Ste 600, Seattle, WA, 98104, for the purchase of Dengue Antigen Mix, Chik Antigen, and Zika Antigen. The statutory authority for this sole source acquisition is 10 U.S.C 2304(c)(1) in accordance with FAR Part 6.302-1- only one responsible source and no other supplies or services will satisfy the agency requirement. The NAICS code for this procurement is 325413, In-Vitro Diagnostic Substance Manufacturing. The purpose of this acquisition is to purchase Dengue, Chik, and Zika Antigen mixes. Inbios International, Inc. is the only responsible source capable of meeting the Government's requirement because they are the only vendor that can manufacture these FDA approved ELISA reagents. CDC diagnostic procedures require these reagents. The use of any other reagents will compromise the results of current CDC processes. Thus, Inbios International, Inc., the manufacturer of these reagents, is the only company that can be used. As a result of this synopsis, no competitive solicitation will be posted on FedBizOpps. We will issue only one solicitation to Inbios International, Inc. However, firms that believe they can meet these requirements are encouraged to identify themselves and give written notice by providing a capability statement to the Contracting Officer by March 4, 2017. The Contracting Officer will not respond to verbal request. All requests must be in writing. A determination by the Government not to compete this proposed action will be based on responses to this notice and are solely within the discretion of the Contracting Officer. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement. Inquiries shall be sent to Liubov Kriel by email at LKriel@cdc.gov and reference solicitation number 2017-Q-66378 on the subject line.
- Web Link
-
FBO.gov Permalink
(https://www.fbo.gov/spg/HHS/CDCP/PGOA/2017-Q-66378/listing.html)
- Place of Performance
- Address: Vendor's address, Seattle, Washington, 98104, United States
- Zip Code: 98104
- Zip Code: 98104
- Record
- SN04407331-W 20170219/170217234643-09cc8adfd372bd40480e4eec8314c531 (fbodaily.com)
- Source
-
FedBizOpps Link to This Notice
(may not be valid after Archive Date)
| FSG Index | This Issue's Index | Today's FBO Daily Index Page |